For four years the answer to "is there a version I can take by mouth?" was no, not for weight loss. On 22 December 2025 that changed. The FDA approved a once-daily 25 mg semaglutide tablet, the same molecule as the Wegovy injection, in a form you swallow.
What happened
Novo Nordisk announced the approval on 22 December 2025. The indication is to reduce excess body weight and maintain that reduction long term, and to reduce the risk of major adverse cardiovascular events. It is the first oral GLP-1 receptor agonist approved for weight management.
The evidence is the OASIS 4 trial, which ran for 64 weeks in adults with obesity, or with overweight and at least one weight-related condition, and excluded people with diabetes. Mean weight loss was 16.6% among those who took the tablet as directed. One person in three lost a fifth of their body weight or more. That is in the same territory as the 2.4 mg injection, which is the point: this is not a weaker option dressed up as a convenience.
What a tablet does not change
The mechanism is identical. Semaglutide slows the stomach and quiets appetite whether it arrives through a needle or through the gut wall, so the side effects are the ones you already know about: nausea, vomiting, diarrhoea, constipation. A tablet is easier to start and no easier to tolerate.
Nor does it change the arithmetic that matters most. Appetite falls faster than the body's need for protein does, and a smaller day with the same protein requirement is the single hardest thing about this class of medicine. The form of the dose has nothing to do with that.
One practical difference is worth knowing. Oral semaglutide is absorbed poorly and unpredictably, which is why the older diabetes tablet, Rybelsus, has to be taken on an empty stomach with a small sip of water and a wait before anything else. If you are moving from an injection to a tablet, the timing rules are new, and they are the part people get wrong. Our guide to taking the Wegovy pill sets out what changes.
What it means for you
If you have wanted to start and could not face a weekly injection, there is now a route that does not involve one. If you are already on an injection and tolerating it, there is no evidence here that says to switch.
What does not move either way is the work underneath. Protein first at every meal, fibre and fluid together, and portions small enough to finish. A tablet makes the medicine easier to take. It does not make the eating easier to get right.
What to do with this
The dose still decides how much you can realistically eat in a day, and the tablet is no exception. Put your medicine and your dose in, and see what your day actually holds.